Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Petzer

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|September 28, 2019
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myelomaHeinz Ludwig, Wolfram Poenisch, Stefan Knop, et al.
Cancers|December 23, 2023
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center ExperienceIrene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, et al.
Breast Cancer Research : BCR|December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-RegistrySimon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Wiener Klinische Wochenschrift|September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 updateGabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Cell Transplantation|August 14, 2025
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysisAlexander Nikoloudis, Veronika Buxhofer-Ausch, Ameya Kunte, et al.
Vaccines|October 28, 2023
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center AnalysisAlexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, et al.
Wiener Klinische Wochenschrift|October 12, 2010
First annual report of the Austrian CML registryStefan Schmidt, Dominik Wolf, Josef Thaler, et al.
Journal of Clinical Medicine|April 26, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic LeukemiaChristina Groiss, Stefanie Kreissl, Irene Strassl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98ARichard F Schlenk, Konstanze Döhner, Silja Mack, et al.
Cytotherapy|January 5, 2025
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideAlexander Nikoloudis, Anna Bauhofer, Lena Griessl, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|September 28, 2019
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myelomaHeinz Ludwig, Wolfram Poenisch, Stefan Knop, et al.
Cancers|December 23, 2023
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center ExperienceIrene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl, et al.
Breast Cancer Research : BCR|December 15, 2021
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-RegistrySimon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, et al.
Wiener Klinische Wochenschrift|September 23, 2022
Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 updateGabriel Rinnerthaler, Christian Singer, Edgar Petru, et al.
Cell Transplantation|August 14, 2025
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysisAlexander Nikoloudis, Veronika Buxhofer-Ausch, Ameya Kunte, et al.
Vaccines|October 28, 2023
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center AnalysisAlexander Nikoloudis, Ines Julia Neumann, Veronika Buxhofer-Ausch, et al.
Wiener Klinische Wochenschrift|October 12, 2010
First annual report of the Austrian CML registryStefan Schmidt, Dominik Wolf, Josef Thaler, et al.
Journal of Clinical Medicine|April 26, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic LeukemiaChristina Groiss, Stefanie Kreissl, Irene Strassl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98ARichard F Schlenk, Konstanze Döhner, Silja Mack, et al.
Cytotherapy|January 5, 2025
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideAlexander Nikoloudis, Anna Bauhofer, Lena Griessl, et al.
Pageof 7